African clinical trial denied access to key COVID drug Paxlovid
Nature, Published online: 04 April 2022; doi:10.1038/d41586-022-00919-5Supply shortages and limits on research leave low- and middle-income countries struggling to access Pfizer’s COVID-19 antiviral.